Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Oral Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: Nucleic Acid Amplification Testing Outcomes in a Randomized, Multicenter Phase 3 Trial (EAGLE-1).
Journal: Open forum infectious diseases
Published: June 18, 2026
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study.
Journal: Lancet (London, England)
Published: December 02, 2024
Safety and immunogenicity of a booster dose of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 2, open-label extension of a phase 1/2 randomised controlled trial.
Journal: The Lancet. Infectious diseases
Published: August 30, 2024
Ending Race-Conscious College Admissions and Its Potential Impact on the Infectious Disease Workforce.
Journal: Open forum infectious diseases
Published: November 30, 2023
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.
Journal: The New England journal of medicine
Published: July 19, 2023
Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.
Journal: Human vaccines & immunotherapeutics
Published: March 04, 2022
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
Journal: The New England journal of medicine
Published: September 15, 2021
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
Journal: The New England journal of medicine
Published: September 15, 2021
Using maternal and neonatal data collection systems for coronavirus disease 2019 (COVID-19) vaccines active safety surveillance in low- and middle-income countries: an international modified Delphi study.
Journal: Gates open research
Published: July 05, 2021
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
Journal: The New England journal of medicine
Published: May 27, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
Journal: The New England journal of medicine
Published: February 17, 2021
Last Updated: 09/26/2026